Distribuzione geografica
Continente #
EU - Europa 2361
NA - Nord America 2164
AS - Asia 1273
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 5806
Nazione #
US - Stati Uniti d'America 2146
CN - Cina 1249
IE - Irlanda 601
UA - Ucraina 547
SE - Svezia 304
FI - Finlandia 259
DE - Germania 256
GB - Regno Unito 163
IT - Italia 111
FR - Francia 67
BE - Belgio 27
NL - Olanda 20
CA - Canada 17
IR - Iran 8
KR - Corea 6
SG - Singapore 5
CO - Colombia 3
EU - Europa 3
RU - Federazione Russa 3
IN - India 2
AT - Austria 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
LB - Libano 1
MU - Mauritius 1
MX - Messico 1
TH - Thailandia 1
TR - Turchia 1
Totale 5806
Città #
Chandler 637
Dublin 599
Jacksonville 559
Nanjing 375
Nanchang 181
Princeton 118
Beijing 115
Shenyang 111
Lawrence 109
Ann Arbor 106
Hebei 104
Wilmington 92
Jiaxing 88
Boardman 84
Changsha 79
Medford 79
Tianjin 79
Hangzhou 54
Milan 53
Verona 45
Helsinki 41
Woodbridge 38
Brussels 27
Norwalk 15
Toronto 13
Auburn Hills 10
Kunming 9
Zhengzhou 9
Borås 7
Jinan 7
Los Angeles 7
Seattle 7
Fairfield 6
Ningbo 6
Berlin 5
Guangzhou 5
Houston 5
Hanover 4
Shanghai 4
Taizhou 4
Zanjan 4
Lanzhou 3
Redwood City 3
Andover 2
Blaubeuren 2
Leawood 2
Noicattaro 2
Nürnberg 2
Ottawa 2
Zelo Buon Persico 2
Aosta 1
Ardabil 1
Ashburn 1
Brooklyn 1
Cagliari 1
Changchun 1
Cologne 1
Corsico 1
Des Moines 1
Fuzhou 1
Geislingen an der Steige 1
Jesi 1
Kemerovo 1
Konya 1
London 1
Madrid 1
Mannheim 1
Markham 1
Nuremberg 1
Orange 1
Piacenza 1
Redmond 1
Rockville 1
Saint Louis 1
Sassari 1
Schwarzach 1
Scranton 1
Seongnam 1
Singapore 1
St Louis 1
Torino 1
Winnipeg 1
Totale 3952
Nome #
Biomedical and functional changes in bronchoalveolar parameters induced by ambroxol treatment of chronic bronchitis 160
Antibiotics and their interaction with the host defense system in vivo. 90
Indoleamine 2,3-dioxygenase in lung allograft tolerance. 82
Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin. 81
Chemotherapeutic agents: aspects of their activity on natural mechanisms of defense against infections 81
Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci 73
Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function 66
Chronic bronchitis and immunomodulating therapy 66
The effect of teicoplanin on leukocytic activity and intraleukocytic micro-organisms 66
A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: a comparison with other Italian reports 66
Effect of glycopeptide antibiotics on human phagocyte activity 64
Is a large number of sputum specimens necessary for the bacteriological diagnosis of tuberculosis? 64
Chemioterapici antitubercolari 64
Fluoroquinolone derivatives: effects on neutrophil functional tests 63
Bronchoalveolar Lavage Fluid Proteome in Bronchiolitis Obliterans Syndrome: Possible Role for Surfactant Protein A in Disease Onset 63
Changes in monocyte chemotaxis in patients with primary lung neoplasia 62
Broncho-alveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to the onset of bronchiolitis obliterans syndrome 62
Systemic inflammatory response and downmodulation of peripheral CD25(+)Foxp3(+) T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer 61
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors 60
Mechanism of action of a rifamycin derivative (AF-013) which is active on the nucleic acid polymerases insensitive to rifampicin 59
Comparison of a whole-blood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection 59
Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations 59
Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis 59
In vitro and ex vivo influence of rifamycins on human phagocytes 58
Effects of continuous or pulsed exposure to rifabutin and sparfloxacin on the intracellular growth of Staphylococcus aureus and Mycobacterium tuberculosis 58
Effect of some R factors on the sensitivity of rough Enterobacteriaceae to human serum 58
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 58
Pharmacokinetics of cofosfolactamines in subjects with impaired kidney function 57
In vitro and ex vivo effect of antimicrobial agents on the chemotaxis of human neutrophils 57
The frequency of Interleukin-10 and Interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted Lung 57
Specific Anti-CMV Reactivity in BAL: A Useful Tool 57
Non specific immunity in aged healthy subjects and in patients with chronic bronchitis 56
Epidemiology of sustained nosocomial gram-positive infections and therapeutic problems 56
Diazepam stimulates migration and phagocytosis of human neutrophils: possible contribution of peripheral-type benzodiazepine receptors and intracellular calcium. 56
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 56
Uptake of flurithromycin by human polymorphonuclear phagocytes: partial characterization of the entry mechanism. 55
Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. 55
Defective phagocyte Aspergillus killing associated with recurrent pulmonary Aspergillus infections 55
Effects of antibiotics on the bactericidal activity of human serum 55
Influence of cefoperazone on neutrophil functions in volunteers 55
Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms? 55
Complement-dependent bactericidal activity for E. coli K12 in serum of preterm newborn infants 55
Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors 55
Effect of beta-lactam antibiotics on migration and bactericidal activity of human phagocytes 54
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 54
Serum bacterial reaction by the alternative pathway of complement: potentiation by target multiplicity and modulation by serum factors 53
Antimicrobial activity, pharmacokinetic characteristics and possible uses of fluoroquinolones 53
Farmacologia moderna con applicazioni cliniche 53
Pharmacological analysis of signal transduction pathways required for mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes 53
In vitro activity of two new oral cephalosporins, cefixime and cefdinir (CI 983), on human peripheral mononuclear and polymorphonuclear leukocyte functions. 53
Evaluation of the host defense system in asthmatic patients 52
Mechanism of action of rifamazine, a member of a new class of (dimeric) rifamycins 52
Function of the defense system in patients with primary neoplasms of the lung. Preliminary results 52
New developments in antibacterial choice for lower respiratory tract infections in elderly patients 52
Antibiotics and inflammatory process: possibile interference 52
Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients 52
In vitro activity of teichomycin against isolates of gram-positive bacteria 51
Effect of rifampicin on expression of some episomal genes in E. coli 51
Genetic bases and mechanisms of bacterial resistance to antibiotic drugs 51
Evidence for CD8+ cell increase in long-term PUVA-treated psoriatic patients after PUVA discontinuation 51
Only genuine CD4+CD25+ Tregs may be friends or foes 51
Cefotaxime: rate of bacterial killing and interactions with serum and leukocyte activity 51
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 51
In vitro effect of RU28965 and other macrolide antibiotics on human neutrophil functions 50
Morphological, ultrastructural, cytochemical and functional analysis of neutrophils deficient in myeloperoxidase 49
Cytokine profile of broncho-alveolar lavage in BOOP and UIP 49
Neutrophil function and opioid receptor expression on leucocytes during chronic naltrexone treatment in humans 49
In vitro and ex vivo effects of cefodizime on human phagocytes 49
Farmaci antielmintici 49
In vitro and ex vivo effect of cefodizime on phagocytosis 49
Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection 48
R-factor-mediated suppression of the galactose-sensitive phenotype of Escherichia coli K-12 galE Mutants 48
Immunological and clinical effect of long-term oral treatment with RU 41740 in patients with chronic bronchitis: double-blind trial long-term versus standard dose regimen 47
Virulence of Mycobacterium tuberculosis affects inteleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes 47
Interference of antimicrobial agents in some reactions of host-defense system 47
Chemokine redundancy in BOS pathogenesis. A possible role also for the CC chemokines: MIP3-beta, MIP3-alpha, MDC and their specific receptors 47
In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime 46
The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis 46
Infezioni polmonari ricorrenti da Aspergillus in un caso di deficit selettivo di aspergillogidia dei fagociti 46
Effect of R factors on rifampicin resistance in E. coli 46
Influence of aging on some specific and nonspecific mechanisms of the host defense system in 146 healthy subjects 45
Direct action of antibiotics and immunomodulating agents on phagocytosis 45
Effects of antimicrobial agents on some phases of neutrophil chemotaxis 45
Lung transplantation: the role of azithromycin in the management of patients with bronchiolitis obliterans syndrome 45
Effects of aminoglycoside antibiotics on neutrophil chemotaxis 45
Mycobacterial lipoarabinomannan differently affects human polymorphonuclear and mononuclear phagocyte functions differently 44
In vitro activity of flurithromycin, a novel macrolide antibiotic 44
A survey of antimicrobial drug resistance in respiratory tract pathogens, isolated in a northern Italian teaching hospital between 1990 and 1999 44
Pleiotropic effects of a rifampicin-resistant mutation in E.coli 44
Lymphopenia and decrease in the total number of circulating CD3+ and CD4+ T cells during 'long-term' PUVA treatment for psoriasis 43
In vitro effect of RU28965 and other macrolide antibiotics on human neutrophil functions 43
Rifamicine 43
Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy 43
Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli 42
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome 42
Infezioni micotiche ricorrenti quale epifenomeno di difetti selettivi di fungicidia dei neutrofili 42
Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. 42
Intraphagocytic bioactivity of flurythromycin and other macrolides against staphylococci 41
Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop 41
Totale 5512
Categoria #
all - tutte 11075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11075

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018190 0000 00 00 017956
2018/2019472 601966 818 1161 1045210
2019/20201605 4406113102 696 2197 6176452
2020/2021993 1027949100 0141 11122 4614814253
2021/2022449 1471310 312 729 291078237
2022/20231750 21410017158 200204 4122 731000
Totale 5827